Literature DB >> 21987454

Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region.

Joris J Blok1, Andries E Braat, Rene Adam, Andrew K Burroughs, Hein Putter, Nigel G Kooreman, Axel O Rahmel, Robert J Porte, Xavier Rogiers, Jan Ringers.   

Abstract

In Eurotransplant, more than 50% of liver allografts come from extended criteria donors (ECDs). However, not every ECD is the same. The limits of their use are being explored. A continuous scoring system for analyzing donor risk has been developed within the Organ Procurement and Transplantation Network (OPTN), the Donor Risk Index (DRI). The objective of this study was the validation of this donor risk index (DRI) in Eurotransplant. The study was a database analysis of all 5939 liver transplants involving deceased donors and adult recipients from January 1, 2003 to December 31, 2007 in Eurotransplant. Data were analyzed with Kaplan-Meier and Cox regression models. Follow-up data were available for 5723 patients with a median follow up of 2.5 years. The mean DRI was remarkably higher in the Eurotransplant region versus OPTN (1.71 versus 1.45), and this indicated different donor populations. Nevertheless, we were able to validate the DRI for the Eurotransplant region. Kaplan-Meier curves per DRI category showed a significant correlation between the DRI and outcomes (P < 0.001). A multivariate analysis demonstrated that the DRI was the most significant factor influencing outcomes (P < 0.001). Among all donor, transplant, and recipient variables, the DRI was the strongest predictor of outcomes.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 21987454     DOI: 10.1002/lt.22447

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  21 in total

1.  Urine biomarkers in renal allograft.

Authors:  Hongting Wang; Zuan-Tao Lin; Yulin Yuan; Tianfu Wu
Journal:  J Transl Int Med       Date:  2016-09-23

Review 2.  [Deceased donor liver transplantation].

Authors:  D Seehofer; W Schöning; P Neuhaus
Journal:  Chirurg       Date:  2013-05       Impact factor: 0.955

3.  High Center Volume Does Not Mitigate Risk Associated with Using High Donor Risk Organs in Liver Transplantation.

Authors:  Eliza W Beal; Sylvester M Black; Khalid Mumtaz; Don Hayes; Ashraf El-Hinnawi; Kenneth Washburn; Dmitry Tumin
Journal:  Dig Dis Sci       Date:  2017-06-01       Impact factor: 3.199

4.  Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5.

Authors:  Brock Macdonald; Justin L Sewell; Ann M Harper; John P Roberts; Francis Y Yao
Journal:  Clin Transplant       Date:  2015-04-28       Impact factor: 2.863

5.  Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience.

Authors:  Sinziana Dumitra; Salleh I Alabbad; Jeffrey S Barkun; Teodora C Dumitra; Dimitrios Coutsinos; Peter P Metrakos; Mazen Hassanain; Steven Paraskevas; Prosanto Chaudhury; Jean I Tchervenkov
Journal:  HPB (Oxford)       Date:  2013-03-14       Impact factor: 3.647

6.  Factors Associated with Mortality and Graft Failure in Liver Transplants: A Hierarchical Approach.

Authors:  Luciana Haddad; Alex Jones Flores Cassenote; Wellington Andraus; Rodrigo Bronze de Martino; Neli Regina de Siqueira Ortega; Jair Minoro Abe; Luiz Augusto Carneiro D'Albuquerque
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

Review 7.  Control of Ischemia-Reperfusion Injury in Liver Transplantation: Potentials for Increasing the Donor Pool.

Authors:  Judith Kahn; Peter Schemmer
Journal:  Visc Med       Date:  2018-10-30

8.  The influence of pharmacological preconditioning with sevoflurane on incidence of early allograft dysfunction in liver transplant recipients.

Authors:  Andrei F Minou; Alexander M Dzyadzko; Aliaksei E Shcherba; Oleg O Rummo
Journal:  Anesthesiol Res Pract       Date:  2012-08-09

9.  Experience Since MELD Implementation: How Does the New System Deliver?

Authors:  Markus Quante; Christoph Benckert; Armin Thelen; Sven Jonas
Journal:  Int J Hepatol       Date:  2012-10-02

10.  Prognostic limitations of the Eurotransplant-Donor Risk Index in liver transplantation.

Authors:  Benedikt Reichert; Alexander Kaltenborn; Alon Goldis; Harald Schrem
Journal:  J Negat Results Biomed       Date:  2013-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.